Analysis of monoclonal antibody oxidation by simple mixed mode chromatography.

Analysis of oxidation of monoclonal antibodies (mAbs) in most cases relies on peptide mapping and LC-MS, which is time consuming and labor-intensive. A robust chromatography based method that is able to resolve and quantitate mAb oxidation variants due to oxidized methionine or tryptophan is highly desired. Here we developed a novel mixed mode chromatography method using the unique property of Sepax Zenix SEC-300MK column to analyze mAb oxidation levels. The separation of oxidized species relied upon the mixed mode of size exclusion and hydrophobic interaction between the resin and antibodies. The chromatography was performed in a regular SEC mobile phase, PBS, containing NaCl at a concentration (0-2.4M) specific for individual antibodies. This method was able to resolve and quantitate the oxidized antibodies as prepeaks, of either methionine-oxidized species induced by the common oxidants TBHP, tryptophan-oxidized species triggered by AAPH, or oxidized species by UV photo-irradiation. The prepeaks were further characterized by SEC-MALLS as monomers and confirmed by LC-MS as oxidized antibody variants with a mass increase of 16 or 32Da. This method has been successfully applied to monitor multiple monoclonal antibodies of IgG1, IgG2, and IgG4 subclasses.

[1]  Y John Wang,et al.  Methionine, tryptophan, and histidine oxidation in a model protein, PTH: mechanisms and stabilization. , 2009, Journal of pharmaceutical sciences.

[2]  A. Takaoka,et al.  Comparing antibody and small-molecule therapies for cancer , 2006, Nature Reviews Cancer.

[3]  Ziping Wei,et al.  Identification of a single tryptophan residue as critical for binding activity in a humanized monoclonal antibody against respiratory syncytial virus. , 2007, Analytical chemistry.

[4]  L. Weiner,et al.  Mechanisms of action of therapeutic antibodies for cancer. , 2015, Molecular immunology.

[5]  Inger Sandlie,et al.  Therapeutic antibodies for human diseases at the dawn of the twenty-first century , 2003, Nature Reviews Drug Discovery.

[6]  A. Ambrogelly,et al.  Enlarging the repertoire of therapeutic monoclonal antibodies platforms: domesticating half molecule exchange to produce stable IgG4 and IgG1 bispecific antibodies. , 2014, Current opinion in biotechnology.

[7]  Ying Zhang,et al.  Analysis and purification of IgG4 bispecific antibodies by a mixed-mode chromatography. , 2015, Analytical biochemistry.

[8]  Hanns-Christian Mahler,et al.  Analytical protein a chromatography as a quantitative tool for the screening of methionine oxidation in monoclonal antibodies. , 2012, Journal of pharmaceutical sciences.

[9]  L. Zitvogel,et al.  Cancer: Antibodies regulate antitumour immunity , 2015, Nature.

[10]  Stephan M. Koza,et al.  Size-Exclusion Chromatography for the Analysis of Protein Biotherapeutics and their Aggregates , 2012, Journal of liquid chromatography & related technologies.

[11]  A. Ambrogelly,et al.  A high throughput ultra performance size exclusion chromatography assay for the analysis of aggregates and fragments of monoclonal antibodies , 2014 .

[12]  Gang Huang,et al.  Methionine oxidation in human IgG2 Fc decreases binding affinities to protein A and FcRn , 2009, Protein science : a publication of the Protein Society.

[13]  Nigel Jenkins,et al.  Post-translational Modifications of Recombinant Proteins: Significance for Biopharmaceuticals , 2008, Molecular biotechnology.

[14]  E. Lissi,et al.  Chemical modification of lysozyme, glucose 6-phosphate dehydrogenase, and bovine eye lens proteins induced by peroxyl radicals: role of oxidizable amino acid residues. , 2013, Chemical research in toxicology.

[15]  I. Kataeva,et al.  Analysis of pH-dependent protein interactions with gel filtration medium. , 1992, Journal of chromatography.

[16]  Ying Zhang,et al.  A new tool for monoclonal antibody analysis , 2014, mAbs.

[17]  Hongcheng Liu,et al.  Heterogeneity of monoclonal antibodies. , 2008, Journal of pharmaceutical sciences.

[18]  A. Therien,et al.  Mechanism of Action and Epitopes of Clostridium difficile Toxin B-neutralizing Antibody Bezlotoxumab Revealed by X-ray Crystallography , 2014, The Journal of Biological Chemistry.

[19]  Igor A Kaltashov,et al.  Advances and challenges in analytical characterization of biotechnology products: mass spectrometry-based approaches to study properties and behavior of protein therapeutics. , 2012, Biotechnology advances.

[20]  Thomayant Prueksaritanont,et al.  Impact of methionine oxidation on the binding of human IgG1 to Fc Rn and Fc gamma receptors. , 2009, Molecular immunology.

[21]  B. Yan,et al.  HIC resolution of an IgG1 with an oxidized Trp in a complementarity determining region. , 2011, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[22]  I. Mellman,et al.  Oncology meets immunology: the cancer-immunity cycle. , 2013, Immunity.

[23]  Mohammed Shameem,et al.  Separation of mAbs molecular variants by analytical hydrophobic interaction chromatography HPLC: overview and applications , 2014, mAbs.

[24]  Guodong Chen,et al.  Structural mass spectrometry in biologics discovery: advances and future trends. , 2012, Drug discovery today.

[25]  Yang Wang,et al.  Impact of methionine oxidation in human IgG1 Fc on serum half-life of monoclonal antibodies. , 2011, Molecular immunology.

[26]  S. Hjertén,et al.  Hydrophobic interaction chromatography on uncharged Sepharose derivatives. Effects of neutral salts on the adsorption of proteins. , 1977 .

[27]  S. Burman,et al.  Facile method of quantification for oxidized tryptophan degradants of monoclonal antibody by mixed mode ultra performance liquid chromatography. , 2012, Journal of chromatography. A.

[28]  J. Queiroz,et al.  Hydrophobic interaction chromatography of proteins. , 2001, Journal of biotechnology.

[29]  Riccardo Torosantucci,et al.  Oxidation of Therapeutic Proteins and Peptides: Structural and Biological Consequences , 2014, Pharmaceutical Research.

[30]  B. Warrack,et al.  Characterization of protein therapeutics by mass spectrometry: recent developments and future directions. , 2011, Drug discovery today.

[31]  Bernhardt L Trout,et al.  A structural and mechanistic study of the oxidation of methionine residues in hPTH(1-34) via experiments and simulations. , 2004, Biochemistry.